Skip to main content
logo
NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,577.00
+31.00 (2.01%)
Aug 12, 2026, 3:30 PM KST

NeoImmuneTech Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
608.5794.82170.38---
Revenue Growth
231.43%-44.35%----
Gross Profit
608.5794.82170.38---
Operating Income
-23,476-25,339-40,972-55,847-58,182-51,906
Net Income
-31,038-31,796-40,883-53,405-60,406-52,482
Earnings Per Share
-232.79-270.20-414.60-540.40-611.60-550.94
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
57,83160,82234,61969,072117,075154,471
Total Debt
10,90910,49210,7713,9084,8515,795
Net Cash (Debt)
46,92150,33023,84965,164112,224148,676
Net Cash Growth
167.75%111.04%-63.40%-41.93%-24.52%117.64%
Net Cash Per Share
351.92427.71241.85659.231136.261560.75

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-24,746-25,053-39,062-49,761-42,405-33,887
Capital Expenditures
108.56-79.64-1,549-791.39-2,477-2,710
Free Cash Flow
-24,638-25,133-40,612-50,552-44,881-36,596
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-3857.66%-26721.84%-24047.07%---
Pretax Margin
-5106.61%-33543.38%-23987.05%---
Profit Margin
-5100.25%-33531.39%-23994.58%---
FCF Margin
-4048.49%-26504.37%-23835.33%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
251.164280.053263.98---